Skip to main content

ORIGINAL RESEARCH article

Front. Aging Neurosci.
Sec. Alzheimer's Disease and Related Dementias
Volume 16 - 2024 | doi: 10.3389/fnagi.2024.1434589
This article is part of the Research Topic The Role of Neuroimaging and Neurostimulation in Detecting and Treating Alzheimer's Disease and Mild Cognitive Impairment View all 7 articles

Machine learning models to diagnose Alzheimer's disease using brain cortical complexity

Provisionally accepted
  • Fujian Medical University Union Hospital, Fuzhou, China

The final, formatted version of the article will be published soon.

    Objective: This study aimed to develop and validate machine learning models (MLMs) to diagnose Alzheimer's disease (AD) using cortical complexity indicated by fractal dimension (FD).: 296 participants with normal cognitive function (NC) and 182 with AD from the AD Neuroimaging Initiative database were randomly divided into training and internal validation cohorts. Then, FDs, demographic characteristics, baseline global cognitive function scales (MOCA, FAQ, GDS, NPI), phospho-tau (P-tau 181), Amyloidβ-42/40, Apolipoprotein E (APOE) and polygenic hazard score (PHS) were collected and established multiple MLMs. Receiver operating characteristic curves were used to evaluate model performance. Participants from our institution (n = 66, 33 with NC and 33 with AD) served as external validation cohorts to validate the MLMs models. Decision curve analysis was used to estimate the models' clinical values.Results: The FDs from 30 out of 69 regions showed significant alteration. All MLMs models were conducted based on the 30 significantly different FDs. FD model had good accuracy in predicting AD in three cohorts (AUC=0.842, 0.808, 0.803). There were no statistically significant differences in AUC values between the FD model and the other combined models in the training and internal validation cohorts except MOCA+FD and FAQ+FD models. AmongMLMs, the MOCA+FD model showed the best predictive efficiency in three cohorts (AUC=0.951, 0.931, 0.955) and had the highest clinical net benefit.The FD model showed favorable diagnostic performance for AD. Among MLMs, the MOCA+FD model can predict AD with the highest efficiency and could be used as a noninvasive method to diagnose AD.

    Keywords: Alzheimer's disease, Montreal Cognitive Assessment, machine learning, Apolipoprotein E, Magnetic Resonance Imaging

    Received: 18 May 2024; Accepted: 27 Sep 2024.

    Copyright: © 2024 Jiang, Yang, Deng, Jiang and Xue. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yunjing Xue, Fujian Medical University Union Hospital, Fuzhou, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.